secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2024-05-24T23:59:59+00:00
Accession:  0001021771-24-000142
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative receives Nasdaq notice for late 10-Q filing; no immediate delisting
--------------------------------------------------------------------------------

- Nasdaq notified BioRestorative on May 22, 2024 of non-compliance with Listing Rule 5250(c)(1) due to delinquent Form 10-Q for Q1 2024.
- Notice has no immediate effect on trading; company has 60 days to submit a plan to regain compliance.
- Nasdaq may grant up to 180 calendar days from the 10-Q due date (Nov 11, 2024) for compliance.
- Delay stems from ongoing restatement analysis previously disclosed in the May 24, 2024 Form 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000102177124000142/0001021771-24-000142-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000102177124000142/brt8k522.htm
  HTML page:      https://secwatch.observer/filing/0001021771-24-000142

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer